《大行》花旗降石药集团(01093.HK)目标价至11.5元 评级“买入”

阿斯达克财经
Mar 26

花旗发表研究报告指,石药集团(01093.HK) 去年收入达260亿元人民币,按年跌10%,纯利达39亿元人民币,按年跌10%;销售费用按年下降25%至65亿元人民币,研发成本增加12%至58亿元人民币。管理阶层持保守态度,预计2026财年业绩将转正。该行指,公司已达成多项卓有成效的业务拓展合作,管理层指出,与阿斯特捷利康(AZN)达成的GLP-1交易的12亿美元预付款预计将于2026年入账。...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10